Izotropic Corporation, a medical device company, develops and commercializes diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a 360-degree computed tomography imaging system designed for breast imaging. The company was incorporated in 2016 and is headquartered in Surrey, Canada.
Stock data | 2023 | Change |
---|---|---|
Price | $0.066 | N/A |
Market Cap | $3.31M | N/A |
Shares Outstanding | 50.09M | 16.22% |
Employees | 0 | N/A |
Shareholder Equity | -3.07M | 720.57% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | -0.60 | N/A |
P/B Ratio | -1.08 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 1.3528 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $0 | N/A |
Earnings | -$4.16M | N/A |
EPS | -0.11 | N/A |
Earnings Yield | -1.67 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $324.74K | N/A |
Total Debt | $1.57M | N/A |
Cash on Hand | $121.70K | N/A |
Debt to Equity | -0.8402 | -83.79% |
Cash to Debt | 0.0775 | -91.54% |
Current Ratio | 0.0917 | -89.22% |